SAVOLITINIB: 73 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
73
Total FAERS Reports
8 (11.0%)
Deaths Reported
60
Hospitalizations
73
As Primary/Secondary Suspect
3
Life-Threatening
1
Disabilities
First Report: 20150120 · Latest Report: 20250423
What Are the Most Common SAVOLITINIB Side Effects?
#1 Most Reported
Hepatic function abnormal
10 reports (13.7%)
#2 Most Reported
Pyrexia
9 reports (12.3%)
#3 Most Reported
Drug-induced liver injury
9 reports (12.3%)
All SAVOLITINIB Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Hepatic function abnormal | 10 | 13.7% | 0 | 10 |
| Drug-induced liver injury | 9 | 12.3% | 0 | 9 |
| Pyrexia | 9 | 12.3% | 0 | 9 |
| Alanine aminotransferase increased | 5 | 6.9% | 0 | 5 |
| Aspartate aminotransferase increased | 5 | 6.9% | 0 | 5 |
| Drug resistance | 5 | 6.9% | 1 | 1 |
| Malignant neoplasm progression | 5 | 6.9% | 1 | 2 |
Who Reports SAVOLITINIB Side Effects? Age & Gender Data
Gender: 60.3% female, 39.7% male. Average age: 62.0 years. Most reports from: CN. View detailed demographics →
Is SAVOLITINIB Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2015 | 3 | 1 | 3 |
| 2016 | 7 | 0 | 7 |
| 2017 | 15 | 2 | 13 |
| 2018 | 7 | 1 | 5 |
| 2019 | 1 | 0 | 1 |
| 2020 | 3 | 0 | 3 |
| 2021 | 6 | 0 | 5 |
| 2022 | 6 | 1 | 5 |
| 2023 | 15 | 1 | 14 |
| 2024 | 1 | 0 | 1 |
| 2025 | 1 | 0 | 0 |
What Is SAVOLITINIB Used For?
| Indication | Reports |
|---|---|
| Non-small cell lung cancer | 37 |
| Lung neoplasm malignant | 7 |
| Non-small cell lung cancer metastatic | 7 |
Official FDA Label for SAVOLITINIB
Official prescribing information from the FDA-approved drug label.